Aclaris Therapeutics
ACRS
ACRS
121 hedge funds and large institutions have $252M invested in Aclaris Therapeutics in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 40 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.8% less ownership
Funds ownership: 79.09% → 77.29% (-1.8%)
15% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 40
Holders
121
Holding in Top 10
3
Calls
$3.49M
Puts
–
Top Buyers
| 1 | +$2.81M | |
| 2 | +$2.23M | |
| 3 | +$1.87M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$994K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$926K |
Top Sellers
| 1 | -$4.82M | |
| 2 | -$3.11M | |
| 3 | -$2.42M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.27M |
| 5 |
Morgan Stanley
New York
|
-$1.67M |
